Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

  19,500      
Direct Value   $6,843,889    

Indirect Value

  $130,455      
Total Shares   312,921      
Total Value   $6,974,344      


Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $982,888 Biocryst Pharmaceuticals Inc
 $409,803 Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $982,888 Biocryst Pharmaceuticals Inc
 $409,803
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    4   
    5    

     Stock price went up :

    0   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   -4.0   
   1.5   
     Percentage Gain/Loss :
   -31.1%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-13 63,339 2019-03-12 0    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-05-15 4 A $0.00 $0 D/D 3,000 248,732 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-06-01 4 A $4.50 $4,998 D/D 1,112 26,204 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-06-25 4 AS $20.00 $200,000 D/D (10,000) 238,732 0 %
ACER Acer Therapeutics Inc Director   –       •      –    2020-07-24 4 B $3.50 $157,500 D/D 45,000 63,905 2.39 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-08-05 4 AS $19.68 $49,200 D/D (2,500) 236,232 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-08-31 4 A $4.15 $9,997 D/D 2,409 28,613 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-11-05 4 AS $21.26 $53,150 D/D (2,500) 233,732 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-11-06 4 AS $23.00 $474,375 D/D (20,625) 213,107 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-11-19 4 GD $0.00 $0 D/D 3,000 210,107 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-11-30 4 A $5.11 $9,995 D/D 1,956 30,569 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-12-02 4 S $23.43 $184,849 D/D (7,891) 202,216 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-12-15 4 S $26.02 $144,385 D/D (5,549) 196,667 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-02-02 4 OE $10.09 $252,250 D/D 25,000 221,667 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-02-02 4 AS $30.75 $768,750 D/D (25,000) 196,667 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-02-04 4 GD $0.00 $0 D/D 25,000 164,794 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-02-04 4 GA $0.00 $0 I/I 25,000 25,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-02-26 4 A $10.78 $9,993 D/D 927 31,496 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-03-17 4 AS $27.35 $486,456 D/D (17,727) 188,940 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-03-17 4 OE $16.23 $162,300 D/D 10,000 206,667 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-04-16 4 OE $16.23 $162,300 D/D 10,000 198,940 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-04-16 4 AS $26.23 $262,300 D/D (10,000) 188,940 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-05-11 4 S $19.58 $42,023 D/D (2,146) 186,794 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-05-14 4 A $0.00 $0 D/D 3,000 189,794 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-05-28 4 A $15.77 $9,998 D/D 634 32,130 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-07-16 4 GA $0.00 $0 I/I 3,000 28,000 0 -

  169  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed